Oral glucocorticoids and risk of psychiatric and suicidal behaviour outcomes: population-based cohort study
Glucocorticoid treatment is associated with elevated risks of serious psychiatric outcomes, including the onset and relapse of common psychiatric disorders. Individuals with psychiatric histories may require additional monitoring during glucocorticoid treatment.
Authors
- Zheng Chang (ORCID: https://orcid.org/0000-0002-8087-1417)
- Henrik Larsson (ORCID: https://orcid.org/0000-0002-6851-3297)
- Julian Forton (ORCID: https://orcid.org/0000-0002-0580-0432)
- Seena Fazel (ORCID: https://orcid.org/0000-0002-5383-5365)
- Paul Lichtenstein (ORCID: https://orcid.org/0000-0003-3037-5287)
- Tyra Lagerberg (ORCID: https://orcid.org/0000-0003-2480-0216)
- Amir Sariaslan (ORCID: https://orcid.org/0000-0002-6151-3278)
- Yasmina Molero (ORCID: https://orcid.org/0000-0002-5663-2010)
- Tapio T Gustafsson
Institutions
- University of Eastern Finland (FI)
- Örebro University (SE)
- Niuvanniemi Hospital (FI)
- Oxford Health NHS Foundation Trust (GB)
- Warneford Hospital (GB)
- Karolinska Institutet (SE)
- University of Oxford (GB)
- Noah's Ark Children's Hospital for Wales (GB)
- Cardiff University (GB)
Publication Details
- Journal
- The British Journal of Psychiatry
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1192/bjp.2025.128
- Citations
- 3
- Primary Topic
- Stress Responses and Cortisol
- Type
- article
- Field-Weighted Citation Impact
- 3.34
Funders
- Wellcome Trust
- National Institute for Health and Care Research
- Department of Health and Social Care
- Oxford Health NHS Foundation Trust